Vranckx, Pascal; Windecker, Stephan; Welsh, Robert C; Valgimigli, Marco; Mehran, Roxana; Dangas, George (2017). Thrombo-embolic prevention after transcatheter aortic valve implantation. European Heart Journal, 38(45), pp. 3341-3350. Oxford University Press 10.1093/eurheartj/ehx390
|
Text
ehx390.pdf - Published Version Available under License Publisher holds Copyright. Download (521kB) | Preview |
Transcatheter aortic valve implantation (TAVI) has emerged as a valuable treatment alternative to surgical aortic valve replacement among patients with symptomatic aortic stenosis at increased surgical risk. The rapid technological evolution from early to current-generation TAVI systems with low-profile delivery catheters, bioprosthetic valves with proven midterm durability, and improved positioning and retrieval features have made important contributions to the widespread clinical use of this minimal invasive therapy. Although peri-procedural and long-term thrombotic and bleeding events after TAVI remain a relevant concern, the optimal antithrombotic strategy and duration to mitigate these risks remain unclear. This review provides an overview of recent insights in this field, and highlights current and future antithrombotic trials focusing on optimizing outcomes in patients undergoing TAVI.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Windecker, Stephan, Valgimigli, Marco |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0195-668X |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Nadia Biscozzo |
Date Deposited: |
08 Feb 2018 11:15 |
Last Modified: |
05 Dec 2022 15:08 |
Publisher DOI: |
10.1093/eurheartj/ehx390 |
PubMed ID: |
29020333 |
Uncontrolled Keywords: |
Anticoagulation Aortic valve TAVI |
BORIS DOI: |
10.7892/boris.107412 |
URI: |
https://boris.unibe.ch/id/eprint/107412 |
Actions (login required)
 |
Edit item |